Literature DB >> 16634121

Outpatient drug safety: new steps in an old direction.

Daniel S Budnitz1, Peter M Layde.   

Abstract

Iatrogenic injury from adverse drug events (ADEs) is a common and often preventable problem in modern medical practice. Attention to this problem has focused on the inpatient hospital setting and healthcare professionals. However, most medication is prescribed and used outside of hospitals and is managed by patients or lay caregivers in homes or workplaces. To address the public health problem of outpatient drug safety, interventions to prevent adverse events must recognize the central role of the patient in medication management and environmental factors specific to the outpatient setting. Lessons and techniques from the field of injury prevention should guide the development and implementation of safety interventions. First, Haddon's phase-factor matrix can be used to help conceptualize outpatient drug safety interventions. Second, interventions to improve outpatient drug safety should be patient-centered and extend beyond patient education to include engineering innovations and enforcement strategies. Third, the sustainability of active versus passive interventions should be considered when choosing safety interventions.

Entities:  

Mesh:

Year:  2007        PMID: 16634121     DOI: 10.1002/pds.1242

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  8 in total

1.  Practical strategies to improve communication with patients.

Authors:  Adam Carlisle; Kara L Jacobson; Lorenzo Di Francesco; Ruth M Parker
Journal:  P T       Date:  2011-09

2.  Patient Engagement In Health Care Safety: An Overview Of Mixed-Quality Evidence.

Authors:  Anjana E Sharma; Natalie A Rivadeneira; Jill Barr-Walker; Rachel J Stern; Amanda K Johnson; Urmimala Sarkar
Journal:  Health Aff (Millwood)       Date:  2018-11       Impact factor: 6.301

3.  Evaluation of Measuring Devices Packaged With Prescription Oral Liquid Medications.

Authors:  Anthony Johnson; Rachel Meyers
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

4.  Beyond the prescription: medication monitoring and adverse drug events in older adults.

Authors:  Michael A Steinman; Steven M Handler; Jerry H Gurwitz; Gordon D Schiff; Kenneth E Covinsky
Journal:  J Am Geriatr Soc       Date:  2011-07-28       Impact factor: 5.562

5.  Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events.

Authors:  Joshua P Metlay; Sean Hennessy; A Russell Localio; Xiaoyan Han; Wei Yang; Abigail Cohen; Charles E Leonard; Kevin Haynes; Stephen E Kimmel; Harold I Feldman; Brian L Strom
Journal:  J Gen Intern Med       Date:  2008-07-10       Impact factor: 5.128

6.  Implementing a clinical pharmacy survey of adverse drug events in a French emergency department.

Authors:  Lucien Roulet; Nathalie Asseray; Martin Dary; Anne Chiffoleau; Gilles Potel; Françoise Ballereau
Journal:  Int J Clin Pharm       Date:  2012-08-25

7.  Feeling better on hemodialysis: user-centered design requirements for promoting patient involvement in the prevention of treatment complications.

Authors:  Matthew A Willis; Leah Brand Hein; Zhaoxian Hu; Rajiv Saran; Marissa Argentina; Jennifer Bragg-Gresham; Sarah L Krein; Brenda Gillespie; Kai Zheng; Tiffany C Veinot
Journal:  J Am Med Inform Assoc       Date:  2021-07-30       Impact factor: 7.942

8.  The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization.

Authors:  Meredith Y Smith; Isma Benattia
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.